You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 165 No. 8, April 25, 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Hypertension
 •Alert me on articles by topic

Elevated Blood Pressure and Risk of End-stage Renal Disease in Subjects Without Baseline Kidney Disease

Chi-yuan Hsu, MD, MSc; Charles E. McCulloch, PhD; Jeanne Darbinian, MPH; Alan S. Go, MD; Carlos Iribarren, MD, MPH, PhD

Arch Intern Med. 2005;165:923-928.

Background  Many cases of end-stage renal disease (ESRD) are ascribed to hypertension. However, because renal disease itself can raise blood pressure, some investigators argue that ESRD seen in patients with hypertension is due to underlying primary renal disease. Previous cohort studies of the relationship between blood pressure and ESRD did not uniformly screen out baseline kidney disease.

Methods  We conducted a historical cohort study among members of Kaiser Permanente of Northern California, a large integrated health care delivery system. The ESRD cases were ascertained by matching with the US Renal Data System registry.

Results  A total of 316 675 adult Kaiser members participated in the Multiphasic Health Checkups from 1964 to 1985. All subjects had estimated glomerular filtration rates of 60 mL /min per 1.73 m2 or higher and negative dipstick urinalysis results for proteinuria or hematuria. During 8 210 431 person-years of follow-up, 1149 cases of ESRD occurred. Compared with subjects with a blood pressure less than 120/80 mm Hg, the adjusted relative risks for developing ESRD were 1.62 (95% confidence interval [CI], 1.27-2.07) for blood pressures of 120 to 129/80 to 84 mm Hg, 1.98 (95% CI, 1.55-2.52) for blood pressures of 130 to 139/85 to 89 mm Hg, 2.59 (95% CI, 2.07-3.25) for blood pressures of 140 to 159/90 to 99 mm Hg, 3.86 (95% CI, 3.00-4.96) for blood pressures of 160 to 179/100 to 109 mm Hg, 3.88 (95% CI, 2.82-5.34) for blood pressures of 180 to 209/110 to 119 mm Hg, and 4.25 (95% CI, 2.63-6.86) for blood pressures of 210/120 mm Hg or higher. Similar associations between blood pressure level and ESRD risk were seen in all subgroup analyses.

Conclusions  Even relatively modest elevation in blood pressure is an independent risk factor for ESRD. The observed relationship does not appear to be due to confounding by clinically evident baseline kidney disease.


Author Affiliations: Departments of Medicine (Drs Hsu and Go) and Epidemiology and Biostatistics (Drs McCulloch, Iribarren, and Go), University of California, San Francisco; and Division of Research, Kaiser Permanente of Northern California, Oakland (Ms Darbinian and Drs Go and Iribarren).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study
Kronborg et al.
Nephrol Dial Transplant 2008;0:gfn148v1-gfn148.
ABSTRACT | FULL TEXT  

Differences in Kidney Function and Incident Hypertension: The Multi-Ethnic Study of Atherosclerosis
Kestenbaum et al.
ANN INTERN MED 2008;148:501-508.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2008;117:e25-e146.
FULL TEXT  

Age Affects Outcomes in Chronic Kidney Disease
O'Hare et al.
J. Am. Soc. Nephrol. 2007;18:2758-2765.
ABSTRACT | FULL TEXT  

Speaker Abstracts: Tuesday, 6 February 2007
Lamb et al.
Nephrol Dial Transplant 2007;22:ix45-ix53.
FULL TEXT  

Metabolic Syndrome--What We Know and What We Don't Know: LPR6 Mutation in a Family with Early Coronary Disease and Metabolic Risk Factors. Science 315: 1278-1282, 2007
Mani et al.
J. Am. Soc. Nephrol. 2007;18:1619-1623.
FULL TEXT  

A Population-Based, Prospective Study of Blood Pressure and Risk for End-Stage Renal Disease in China
Reynolds et al.
J. Am. Soc. Nephrol. 2007;18:1928-1935.
ABSTRACT | FULL TEXT  

Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2007;115:e69-e171.
FULL TEXT  

Exploring Secular Trends in the Likelihood of Receiving Treatment for End-Stage Renal Disease
Hsu et al.
CJASN 2007;2:81-88.
ABSTRACT | FULL TEXT  

Prospective Study of the Effect of Blood Pressure on Renal Function in Old Age: The Leiden 85-Plus Study
van Bemmel et al.
J. Am. Soc. Nephrol. 2006;17:2561-2566.
ABSTRACT | FULL TEXT  

Cross-Talk between the Kidney and the Cardiovascular System
Amann et al.
J. Am. Soc. Nephrol. 2006;17:2112-2119.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.